Rapid diagnosis of MCAD deficiency: Quantitative analysis of octanoylcarnitine and other acylcarnitines in newborn blood spots by tandem mass spectrometry

Clinical Chemistry

Volumn 43, Issue 11, 1997, Pages 2106-2113

  Chace, Donald H ^a,b   Hillman, Steven L ^a   Van Hove, Johan L K ^a   Naylor, Edwin W ^a  

^a Neo Gen Screening Inc   (United States)

^b DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACYLCARNITINE; CARNITINE; MEDIUM CHAIN ACYL COENZYME A DEHYDROGENASE;

ARTICLE; DATA ANALYSIS; DIAGNOSTIC ACCURACY; DRUG SCREENING; ENZYME ACTIVITY; ENZYME DEFICIENCY; QUANTITATIVE DIAGNOSIS; SPECTROMETRY; SUDDEN DEATH; TANDEM MASS SPECTROMETRY;

EID: 0030664016     PISSN: 00099147     EISSN: None     Source Type: Journal    
DOI: 10.1093/clinchem/43.11.2106     Document Type: Article

References (22)

1. Iafolla AK, Thompson RJ, Roe CR. Medium-chain acyl-coenzyme A dehydrogenase deficiency: clinical course in 120 affected children. J Pediatr 1994;124:409-15.
2. Roe CR, Coates PM. Mitochondrial fatty acid oxidation disorders. In: Scriver CR, Beaudet AL, Sly WS, Valle D, eds. The metabolic and molecular bases of inherited disease, 7th ed. New York: McGraw-Hill, 1995:1501-33.
3. Roe CR, Millington DS, Maltby DA, Kinnebrew P. Recognition of medium-chain acyl-CoA dehydrogenase deficiency in asymptomatic siblings of children dying of sudden infant death or Reye-like syndromes. J Pediatr 1986;108:13-8.
4. Workshop on Molecular Aspects of MCAD Deficiency. Mutations causing medium-chain acyl-coA dehydrogenase deficiency: a collaborative compilation of the data from 172 patients. Prog Clin Biol Res 1992;375:499-506.
5. Gregersen N, Winter V, Curtis D, Deufel T, Mack M, Hendrickx J, et al. Medium-chain acyl-CoA dehydrogenase (MCAD) deficiency: the prevalent mutation G985 (K304E) is subject to a strong founder effect from Northwestern Europe. Hum Hered 1993;43:342-50.
6. Medium chain acyl CoA dehydrogenase deficiency [Editorial]. Lancet 1991;338:544-5.
7. Matsubara Y, Narisawa K, Tada K, Hioruki I, YeQi Y, Danks D, et al. Prevalence of K329E mutation in medium-chain acyl-CoA dehydrogenase gene determined from Guthrie cards. Lancet 1991;338:552-3.
8. Heales SJR, Leonard JV. Diagnosis of medium chain acyl CoA dehydrogenase deficiency by measurement of cis-4-decenoic acid in dried blood spots. Clin Chim Acta 1992;209:61-6.
9. Bennett MJ, Ragni MC, Ostfeld RJ, Robert J, Santer R, Schmidt-Sommerfelt E, et al. Population screening for medium-chain acyl-CoA dehydrogenase deficiency: analysis of medium-chain fatty acids and acylglycines in blood spots. Ann Clin Biochem 1994;31:72-7.
10. Millington DS, Kodo N, Roe CR. Tandem mass spectrometry: a new method for acylcarnitine profiling with potential for neonatal screening for inborn errors of metabolism. J Inherit Metab Dis 1990;13:321-4.
11. Van Hove JLK, Zhang W, Kahler SG, Roe C, Chen YT, Terada N, et al. Medium-chain acyl-CoA dehydrogenase (MCAD) deficiency: diagnosis by acylcarnitine analysis in blood. Am J Hum Genet 1993;52:958-66.
12. Millington DS, Chace DH, Hillman SL, Kodo N, Terada N, et al. Diagnosis of metabolic disease. In: Matsuo T, Caprioli RM, Gross ML, Seyama Y, eds. Biological mass spectrometry: present and future. New York: John Wiley & Sons, 1994:559-79.
13. Chace DH, Millington DS, Terada N, Kahler S, Roe C, Hofman L. Rapid diagnosis of phenylketonuria by quantitative analysis of phenylalanine and tyrosine in neonatal blood spots by tandem mass spectrometry. Clin Chem 1993;39:66-71.
14. Chace DH, Hillman SL, Millington DS, Kahler S, Adam B, Levy H, et al. Rapid diagnosis of homocystinuria and other hypermethioninemias from newborns' blood spots by tandem mass spectrometry. Clin Chem 1996;42:349-55.
15. Chace DH, Hillman SL, Millington DS, Kahler S, Roe C, Naylor E. Rapid diagnosis of maple syrup urine disease in blood spots from newborns by tandem mass spectrometry. Clin Chem 1995;41:62-8.
16. National Committee for Clinical Chemistry Standards. Blood collection on filter paper for neonatal programs: approved standard. NCCLS Publication LA4-A, Villanova, PA: NCCLS, 1988.
17. Chace DH, Millington DS, Hillman SL. The role of tandem mass spectrometry in reducing the number of false positive and false negative results in the diagnosis of metabolic disease from dried blood spots. In: Pass K, Levy H, eds. Early hospital discharge: impact on newborn screening, the council of regional networks for genetics services. Atlanta, GA: Emory University School of Medicine, 1995:272-83.
18. Schmidt-Sommerfeld E, Penn D, Duran M, Bennett MJ, Sanier R, Stanley CA. Detection of inborn errors of fatty acid oxidation from acylcarnitine analysis of plasma and blood spots with the radioisotopic exchange-high-performance liquid chromatographic method. J Pediatr 1993;122:708-14.
19. Rashed MS, Ozand PT, Bucknall MP, Little D. Diagnosis of inborn errors of metabolism from blood spots by acylcarnitines and amino acids profiling using automated electrospray tandem mass spectrometry. Pediatr Res 1995;38:324-31.
20. Ziadeh R, Huffman EP, Finegold DM, Hoop R, Brackett J, Strauss A, Naylor E. Medium chain acyl-CoA dehydrogenase deficiency in Pennsylvania: neonatal screening shows high incidence and unexpected mutation frequencies. Pediatr Res 1995;37:675-8.
21. Catzeflis C, Bachmann C, Hale DE, Coates P, Wiesmann U, Columbo J, et al. Early diagnosis and treatment of neonatal medium-chain acyl-CoA dehydrogenase deficiency: report in two siblings. Eur J Pediatr 1990;149:577-81.
22. Brackett JC, Sims HF, Steiner RD, Nunge M, Zimmerman E, deMartinville B, et al. A novel mutation in medium chain acyl-CoA dehydrogenase causes sudden neonatal death. J Clin Invest 1994;94:1477-83.